PMID- 21688623 OWN - NLM STAT- MEDLINE DCOM- 20110722 LR - 20110727 IS - 0047-1852 (Print) IS - 0047-1852 (Linking) VI - 69 IP - 6 DP - 2011 Jun TI - [Proton pump inhibitor H2 receptor antagonist]. PG - 1032-8 AB - Recently, Japanese guidelines for the treatment and prevention of peptic ulcers were established by the Japanese Society of Gastroenterology. Herein, we focus on proton pump inhibitor(PPI) and H2 receptor antagonist (H2RA) for prophylaxis and treatment of peptic ulcer associated with NSAIDs including low dose of aspirin. Double dose of H2RAs are effective at preventing chronic NSAID related ulcers, however, the effect is not superior to PPI. Full-dose misoprostol and PPI are clinically equivalent, although the potential adverse effects of misoprostol are a major cause of poor compliance. Overall, PPIs have the best profile of efficacy and side-effects for the healing and prevention of NSAID-associated ulcers, especially in the patients with high risk, such as history of peptic ulcer. FAU - Shiotani, Akiko AU - Shiotani A AD - Department of Internal Medicine, Kawasaki Medical School. FAU - Kamada, Tomoari AU - Kamada T FAU - Kusunoki, Hiroaki AU - Kusunoki H FAU - Manabe, Noriaki AU - Manabe N FAU - Haruma, Ken AU - Haruma K LA - jpn PT - English Abstract PT - Journal Article PT - Review PL - Japan TA - Nihon Rinsho JT - Nihon rinsho. Japanese journal of clinical medicine JID - 0420546 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Histamine H2 Antagonists) RN - 0 (Proton Pump Inhibitors) SB - IM MH - Anti-Inflammatory Agents, Non-Steroidal/*adverse effects MH - Histamine H2 Antagonists/*therapeutic use MH - Humans MH - Peptic Ulcer/*chemically induced/*drug therapy/prevention & control MH - Proton Pump Inhibitors/*therapeutic use EDAT- 2011/06/22 06:00 MHDA- 2011/07/23 06:00 CRDT- 2011/06/22 06:00 PHST- 2011/06/22 06:00 [entrez] PHST- 2011/06/22 06:00 [pubmed] PHST- 2011/07/23 06:00 [medline] PST - ppublish SO - Nihon Rinsho. 2011 Jun;69(6):1032-8.